MRS4596
MRS4596 is a potent and selective P2X4 receptor antagonist with an IC50 value of 1.38 μM for human P2X4 receptor. MRS4596 has neuroprotective and neuro-rehabilitative activities in ischemic stroke model. MRS4596 can be used in research of ischemic stroke .
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2840581-38-4
- Formule: C22H15N4NaO3S
- Masse moléculaire:438.43
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform P2X Receptor
More
Activité biologique
IC50: 1.38 μM (human P2X4 receptor)[1]
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male and female young C57B/6 mice (8-12 weeks; induced transient focal cerebral ischemia by a 60 min right middle cerebral artery occlusion)[1]
-
Dosage:5 mg/kg
-
Administration:3 days continuous infusion with an Alzet minipump
-
Result:Decreased in total hemispheric infarct volume while effects were not significant on cortical or striatal infarct volume alone.
Chemical Information
-
CAS No. 2840581-38-4
-
Masse moléculaire 438.43
-
Formule C22H15N4NaO3S
-
SMILES
O=C(C1)NC(C2=CC=C(C=C2C=C3)C)=C3N(C4=CC=CC(C([N-]5)=NOC5=S)=C4)C1=O.[Na+]
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)